StemSation International is providing updates on corporate planning and direction for potential new acquisitions in the green energy space
Plantation, Florida, September 27, 2023 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing strategic acquisition planning for the upcoming months.
“We announced last month that we had streamlined our current business and would be seeking further licensing opportunities and asset acquisitions,” stated Benjamin Silber, CEO of StemSation International. “Working closely with advisors, we are concentrating on business segments with proven growth. We have now focused on green energy companies as acquisition targets,” he continued. “We have started negotiations to acquire a company that is already in the solar energy space. We will keep everyone informed as we move these projects forward. We are excited to move this business forward as we seek other licensing opportunities and asset acquisitions,” he concluded.
According to the Solar Energy Industries Association (SEIA), there are now more than 155 gigawatts (GW) of solar capacity installed nationwide; enough to power 27 million homes. The market grew over 40% last year alone with expected growth increases over the next 20 years.
StemSation expects to have additional updates shortly as they fulfill on their current business plan.
About StemSation International
StemSation International, Inc. (OTC: STSN) is researching the developing, marketing and distribution of flavored, canned oxygen products. These products will be distributed in a lifestyle model to the beverage industry as well as colleges, restaurants and bars. StemSation is headquartered in Plantation, Florida.
Contact:
StemSation International
Benjamin Silber
SEC Disclaimer
This press release contains forward-looking statements. The words or phrases “would be,” “will allow,” “intends to,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” or similar expressions are intended to identify “forward-looking statements.” Actual results could differ materially from those projected in StemSation international’s (“the Company”) business plan. The announcement of acquisition plans should not be construed as an indication in any way whatsoever of the future value of the Company’s common stock or its financial value. The Company’s filings may be accessed at the OTC Market’s disclosures at www.otcmarkets.com Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
Source: StemSation International, Inc.
